Biomea Fusion, Inc.
NASDAQ:BMEA
8.69 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 6.142 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.4 | 0.42 | 1.13 | 1.11 | 1.056 | 0.905 | 0.326 | 0.344 | 0.312 | 0.166 | 0.288 | 0.25 | 0.322 | 0.092 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.4 | -0.42 | 5.012 | -1.11 | -1.056 | -0.905 | -0.326 | -0.344 | -0.312 | -0.166 | -0.288 | -0.25 | -0.322 | -0.092 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.816 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 31.825 | 33.776 | 30.866 | 25.347 | 21.938 | 24.395 | 20.539 | 18.242 | 12.582 | 11.35 | 11.088 | 7.886 | 5.224 | 3.798 | 2.332 | 0.789 | 0.216 | 0.334 |
| General & Administrative Expenses
| 7.073 | 7.283 | 6.462 | 5.772 | 5.719 | 5.636 | 5.737 | 5.242 | 4.892 | 5.05 | 3.649 | 4.752 | 3.211 | 2.059 | 1.167 | 0.346 | 0.079 | 0.064 |
| Selling & Marketing Expenses
| -0.4 | -0.42 | -1.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.673 | 6.863 | 5.332 | 5.772 | 5.719 | 5.636 | 5.737 | 5.242 | 4.892 | 5.05 | 3.649 | 4.752 | 3.211 | 2.059 | 1.167 | 0.346 | 0.079 | 0.064 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 38.498 | 40.639 | 36.198 | 31.119 | 27.657 | 30.031 | 26.276 | 23.484 | 17.474 | 16.4 | 14.737 | 12.638 | 8.435 | 5.857 | 3.499 | 1.135 | 0.295 | 0.398 |
| Operating Income
| -38.898 | -41.059 | -37.328 | -31.119 | -27.657 | -30.031 | -26.276 | -23.484 | -17.474 | -16.4 | -14.737 | -12.638 | -8.435 | -5.857 | -3.499 | -1.135 | -0.295 | -0.398 |
| Operating Income Ratio
| 0 | 0 | -6.077 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.622 | 1.998 | 2.444 | 2.69 | 2.766 | 0.98 | 0.962 | 0.594 | 0.216 | 0.034 | 0.027 | 0.032 | 0.036 | 0.005 | 0.001 | 0 | 0.002 | 0 |
| Income Before Tax
| -37.276 | -39.061 | -34.884 | -28.429 | -24.891 | -29.051 | -25.314 | -22.89 | -17.258 | -16.366 | -14.71 | -12.606 | -8.399 | -5.852 | -3.498 | -1.135 | -0.293 | -0.398 |
| Income Before Tax Ratio
| 0 | 0 | -5.68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.377 | 1.782 | -0.419 | -0.383 | -0.98 | -1.212 | -0.594 | -0.142 | -0.034 | -0.15 | -0.185 | -0.299 | -0.081 | 0 | 0 | -0.295 | -0.398 |
| Net Income
| -37.276 | -39.061 | -34.884 | -28.429 | -24.891 | -28.071 | -24.102 | -22.296 | -17.258 | -16.332 | -14.71 | -12.606 | -8.399 | -5.852 | -3.498 | -1.135 | -0.293 | -0.398 |
| Net Income Ratio
| 0 | 0 | -5.68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.03 | -1.09 | -0.97 | -0.8 | -0.7 | -0.95 | -0.82 | -0.76 | -0.59 | -0.56 | -0.51 | -0.43 | -0.33 | -0.21 | -0.13 | -0.11 | -0.027 | -0.037 |
| EPS Diluted
| -1.03 | -1.09 | -0.97 | -0.8 | -0.7 | -0.95 | -0.82 | -0.76 | -0.59 | -0.56 | -0.51 | -0.43 | -0.33 | -0.21 | -0.13 | -0.11 | -0.027 | -0.037 |
| EBITDA
| -38.498 | -40.639 | -36.198 | -31.119 | -27.657 | -30.031 | -26.276 | -23.484 | -17.304 | -16.234 | -14.737 | -12.573 | -8.412 | -5.846 | -3.493 | -1.133 | -0.295 | -0.398 |
| EBITDA Ratio
| 0 | 0 | -5.894 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |